Back to search

Switzerland· 66015010

Amlodipin Valsartan Sandoz

A valsartan and amlodipine product containing amlodipinum, valsartanum, registered in Switzerland and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 14 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC C09DB01

Checked against BAG Spezialitätenliste (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHBAG Spezialitätenliste (Switzerland)normalisedAmlodipin Valsartan SandozATCC09DB01REGISTER NO.66015010PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Valsartan and amlodipine is registered in 14 of 19 countries.

Countries holding a registration under ATC C09DB01 (valsartan and amlodipine), each read from that country’s own register.

  • This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
  • 10 of them publish a price we can compare per daily dose

Valsartan and amlodipine · ATC C09DB01

14 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

BAG Spezialitätenliste (Switzerland)
Active substance
amlodipinum, valsartanum
Manufacturer
—
Country
Switzerland (CH)
ATC code
C09DB01
ATC class
Valsartan and amlodipine
Swissmedic category
B
Reimbursed
Yes
Source register
BAG Spezialitätenliste (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680660150104
    Blist 28 Stk
    CHF 27.9

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

81 interactions on record for valsartan and amlodipine.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Valsartan and amlodipine · interactions on record

81 records

81 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Valsartan and amlodipine in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All valsartan and amlodipine products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Amlodipin/Valsartan +pharma, Amlodipin/Valsartan 1a Pharma
  • Belgium · Amlodipine/Valsartan Eg, Amlodipine/Valsartan Krka
  • Bulgaria · Aзбима, Валдипин Дуо
  • Cyprus · Valsimia
  • Czechia · Asbima, Wamlox
  • Germany · Amlo-Valsacor, Amlodipin Hexal Plus Valsartan Hexal
  • Denmark · Amlodipin/Valsartan Stada
  • Estonia · Wamlox
  • Spain · Amlodipino/Valsartán Aurovitas, Amlodipino/Valsartán Cinfamed
  • Finland · Amlodipin/Valsartan Krka, Amlodipin/Valsartan Orion
  • France · Amlodipine/Valsartan Accord, Amlodipine/Valsartan Arrow
  • United Kingdom (Northern Ireland) · Amlodipine / Valsartan Zentiva Pharma
  • Greece · Alvoda, Amlodipine+valsartan Tad
  • Croatia · Dipperam, Vainas
  • Hungary · Amlodipin/Valsartan Krka Pharma, Amlodipin/Valsartan Sandoz
  • Ireland · Amlodipine/Valsartan Clonmel, Amlodipine/Valsartan Krka
  • Iceland · Amlodipine/Valsartan Mylan, Copalia
  • Italy · Amlodipina E Valsartan Doc, Amlodipina E Valsartan Krka Pharma
  • Liechtenstein · Amlodipine/Valsartan Mylan, Copalia
  • Lithuania · Amlodipine/Valsartan Ingen Pharma, Dipperam
  • Luxembourg · Amlodipine/Valsartan Eg
  • Latvia · Wamlox
  • Netherlands · Amlodipine Besylate/Valsartan Aurobindo, Amlodipine/Valsartan Sandoz
  • Norway · Amlodipin/Valsartan Krka, Amlodipine/Valsartan Mylan
  • Poland · Avasart Plus, Dipperam
  • Portugal · Amlodipina / Valsartan Macleods, Amlodipina + Valsartan Alter
  • Romania · Amlodipină/Valsartan Stada, Bevacomb
  • Sweden · Amlodipin/Valsartan Actavis, Amlodipin/Valsartan Denk
  • Slovenia · Wamlox
  • Slovakia · Amlodipín/Valsartan Sandoz, Wamlox

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/3f18fcd8-f320-4e3e-9d5d-ec87267df900
GET /v1/drugs/3f18fcd8-f320-4e3e-9d5d-ec87267df900?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "amlodipinum 5 mg + valsartanum 80 mg",
  "valid_from": "2020-12-01",
  "limitations": "[{\"description\":\"Die gleichzeitige Therapie mit AMLODIPIN VALSARTAN SANDOZ und einem Calciumantagonisten des I.T. 02.06 und/oder einem Angiotensin-II-Antagonisten und/oder einem ACE-Hemmer wird von der obligatorischen Krankenpflegeversicherung nicht vergütet.\",\"costApproval\":null,\"indication\":\"\",\"isNew\":false,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2025-10-01\",\"validTo\":null}]",
  "galenic_form": "Filmtabl 5/80",
  "therapeutic_area": null,
  "sl_inclusion_date": "2020-12-01",
  "self_retention_pct": 10
}

See everything about valsartan and amlodipine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.